Variant report

Variant	esv3500953
Chromosome Location	chr12:123184899-123189597
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:49)
CpG islands
(count:368)
Chromatin interactive
region (count:1)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:49 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BATF	chr12:123184904-123185288	GM12878	blood:	n/a	n/a
2	BATF	chr12:123184951-123185203	GM12878	blood:	n/a	n/a
3	BCL11A	chr12:123184925-123185178	GM12878	blood:	n/a	chr12:123185140-123185149
4	CEBPB	chr12:123187794-123188089	HepG2	liver:	n/a	n/a
5	CEBPB	chr12:123187833-123188233	Hela-S3	cervix:	n/a	n/a
6	CEBPB	chr12:123187869-123188146	A549	lung:	n/a	n/a
7	E2F4	chr12:123187896-123188134	MCF10A-Er-Src	breast:	n/a	n/a
8	EBF1	chr12:123187913-123188259	GM12878	blood:	n/a	n/a
9	EBF1	chr12:123187949-123188264	GM12878	blood:	n/a	n/a
10	EP300	chr12:123187789-123188123	HepG2	liver:	n/a	n/a
11	FOS	chr12:123187570-123188311	MCF10A-Er-Src	breast:	n/a	n/a
12	FOS	chr12:123187706-123188305	MCF10A-Er-Src	breast:	n/a	n/a
13	FOS	chr12:123187821-123188180	MCF10A-Er-Src	breast:	n/a	n/a
14	FOS	chr12:123187796-123188158	MCF10A-Er-Src	breast:	n/a	n/a
15	FOSL2	chr12:123184573-123184941	HepG2	liver:	n/a	chr12:123184777-123184784 chr12:123184772-123184783 chr12:123184772-123184784 chr12:123184774-123184782
16	FOXA1	chr12:123187806-123188302	HepG2	liver:	n/a	n/a
17	FOXA1	chr12:123187829-123188220	HepG2	liver:	n/a	n/a
18	FOXA2	chr12:123187936-123188118	HepG2	liver:	n/a	n/a
19	HEY1	chr12:123187714-123188013	HepG2	liver:	n/a	n/a
20	IRF4	chr12:123184590-123185349	GM12878	blood:	n/a	n/a
21	IRF4	chr12:123184845-123185339	GM12878	blood:	n/a	n/a
22	MYC	chr12:123187728-123188305	MCF10A-Er-Src	breast:	n/a	n/a
23	MYC	chr12:123187750-123188250	MCF10A-Er-Src	breast:	n/a	n/a
24	NFIC	chr12:123184737-123185315	GM12878	blood:	n/a	n/a
25	PAX5	chr12:123184834-123185208	GM12878	blood:	n/a	chr12:123185140-123185149
26	POLR2A	chr12:123186413-123186760	MCF10A-Er-Src	breast:	n/a	n/a
27	POLR2A	chr12:123187704-123188015	Hela-S3	cervix:	n/a	n/a
28	POLR2A	chr12:123187655-123188092	MCF10A-Er-Src	breast:	n/a	n/a
29	POLR2A	chr12:123187757-123187873	HepG2	liver:	n/a	n/a
30	POLR2A	chr12:123186895-123186998	HUVEC	blood vessel:	n/a	n/a
31	POLR2A	chr12:123185972-123186119	MCF10A-Er-Src	breast:	n/a	n/a
32	POLR2A	chr12:123187462-123188263	MCF10A-Er-Src	breast:	n/a	n/a
33	POU2F2	chr12:123188001-123188214	GM12878	blood:	n/a	n/a
34	POU2F2	chr12:123187839-123188275	GM12878	blood:	n/a	n/a
35	SP1	chr12:123184917-123185192	GM12878	blood:	n/a	n/a
36	SP1	chr12:123184902-123185193	GM12878	blood:	n/a	n/a
37	SPI1	chr12:123184645-123185493	GM12878	blood:	n/a	chr12:123184835-123184842 chr12:123185169-123185182 chr12:123185140-123185149
38	SPI1	chr12:123184653-123185305	GM12878	blood:	n/a	chr12:123184835-123184842 chr12:123185169-123185182 chr12:123185140-123185149
39	SPI1	chr12:123185014-123185250	GM12878	blood:	n/a	chr12:123185169-123185182 chr12:123185140-123185149
40	SPI1	chr12:123184974-123185267	GM12891	blood:	n/a	chr12:123185169-123185182 chr12:123185140-123185149
41	SPI1	chr12:123184707-123185335	GM12891	blood:	n/a	chr12:123184835-123184842 chr12:123185169-123185182 chr12:123185140-123185149
42	STAT3	chr12:123187750-123188301	MCF10A-Er-Src	breast:	n/a	n/a
43	STAT3	chr12:123187528-123188305	MCF10A-Er-Src	breast:	n/a	chr12:123187645-123187666
44	STAT3	chr12:123187514-123188307	MCF10A-Er-Src	breast:	n/a	chr12:123187645-123187666
45	STAT3	chr12:123187510-123188458	MCF10A-Er-Src	breast:	n/a	chr12:123187645-123187666
46	STAT3	chr12:123187886-123188097	Hela-S3	cervix:	n/a	n/a
47	TAF1	chr12:123187760-123188010	Hela-S3	cervix:	n/a	n/a
48	ZNF217	chr12:123187472-123187769	MCF-7	breast:	n/a	n/a
49	ZNF384	chr12:123187960-123188015	K562	blood:	n/a	n/a

(count:368 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:123187474-123187524	GM06990	blood:	n/a
2	chr12:123187073-123187123	LNCaP	prostate:	n/a
3	chr12:123187474-123187524	GM06990	blood:	n/a
4	chr12:123187073-123187123	LNCaP	prostate:	n/a
5	chr12:123189236-123189286	HCM	heart:	n/a
6	chr12:123188078-123188128	HAEpiC	amniotic membrane:	n/a
7	chr12:123189256-123189306	NT2-D1	testis:	n/a
8	chr12:123187073-123187123	SKMC	muscle:	n/a
9	chr12:123188078-123188128	Hepatocyte	liver:	n/a
10	chr12:123189236-123189286	H1-hESC	embryonic stem cell:	embryo
11	chr12:123189236-123189286	LNCaP	prostate:	n/a
12	chr12:123189236-123189286	GM12891	blood:	n/a
13	chr12:123187474-123187524	AG04449	skin:	fetal
14	chr12:123189256-123189306	NHDF-neo	bronchial:	n/a
15	chr12:123189236-123189286	IMR90	lung:	fetal
16	chr12:123187474-123187524	HNPCEpiC	eye:	n/a
17	chr12:123188078-123188128	HCF	heart:	n/a
18	chr12:123189256-123189306	SK-N-SH	brain:	n/a
19	chr12:123187474-123187524	SAEC	small airway:	n/a
20	chr12:123187529-123187579	GM19239	blood:	n/a
21	chr12:123187529-123187579	AG09309	skin:	n/a
22	chr12:123187529-123187579	PANC-1	pancreas:	n/a
23	chr12:123187474-123187524	AG09309	skin:	n/a
24	chr12:123187529-123187579	Jurkat	blood:	n/a
25	chr12:123188078-123188128	HCPEpiC	choroid plexus:	n/a
26	chr12:123189256-123189306	ovcar-3	ovarian:	n/a
27	chr12:123187529-123187579	BJ	skin:	n/a
28	chr12:123188078-123188128	HNPCEpiC	eye:	n/a
29	chr12:123189236-123189286	T-47D	breast:	n/a
30	chr12:123189236-123189286	GM06990	blood:	n/a
31	chr12:123187474-123187524	PrEC	prostate:	n/a
32	chr12:123189256-123189306	HepG2	liver:	n/a
33	chr12:123187474-123187524	GM12892	blood:	n/a
34	chr12:123189236-123189286	Caco-2	colon:	n/a
35	chr12:123189236-123189286	NT2-D1	testis:	n/a
36	chr12:123188078-123188128	HRCEpiC	kidney:	n/a
37	chr12:123188078-123188128	MCF-7	breast:	n/a
38	chr12:123189256-123189306	MCF-7	breast:	n/a
39	chr12:123188078-123188128	AG04449	skin:	fetal
40	chr12:123187073-123187123	T-47D	breast:	n/a
41	chr12:123189256-123189306	AG10803	skin:	n/a
42	chr12:123187529-123187579	AoSMC	blood vessel:	n/a
43	chr12:123187073-123187123	Jurkat	blood:	n/a
44	chr12:123187529-123187579	K562	blood:	n/a
45	chr12:123187073-123187123	AG09309	skin:	n/a
46	chr12:123187529-123187579	SKMC	muscle:	n/a
47	chr12:123188078-123188128	Jurkat	blood:	n/a
48	chr12:123189236-123189286	PANC-1	pancreas:	n/a
49	chr12:123187474-123187524	Hela-S3	cervix:	n/a
50	chr12:123187529-123187579	LNCaP	prostate:	n/a

(count:1 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr12:123186486..123188573-chr12:123199930..123201817,2	MCF-7	breast:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-DENR-2	chr12:123185843-123186416	NONHSAT031529

No data

Variant related genes	Relation type
HCAR2	TF binding region
HCAR2	CpG island
ENSG00000255398	chromatin interactions

Extended variants
information (count: 336 )
Associated
traits (count: 68 )

Variant overlapped rSNPs/rCNVs (count:336 , 50 per page) page: 1 2 3 4 5 6 7

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs543699524	chr12:123184935-123184936	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs148147685	chr12:123184963-123184964	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs599145	chr12:123185133-123185134	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	mRNA abundance
4	rs183621377	chr12:123185308-123185309	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs523732	chr12:123185314-123185315	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs111679231	chr12:123185327-123185328	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs523030	chr12:123185336-123185337	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs547583483	chr12:123185368-123185369	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs559911825	chr12:123185371-123185372	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs188320480	chr12:123185407-123185408	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs573009201	chr12:123185416-123185417	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs139180810	chr12:123185423-123185424	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs181061793	chr12:123185428-123185429	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs570027755	chr12:123185479-123185480	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs545471658	chr12:123185496-123185497	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs597365	chr12:123185538-123185539	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs76566182	chr12:123185545-123185546	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs549275250	chr12:123185550-123185551	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs567584634	chr12:123185553-123185554	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs71440208	chr12:123185554-123185555	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs78719322	chr12:123185555-123185556	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs565673705	chr12:123185558-123185559	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs146478919	chr12:123185563-123185564	Enhancers Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs586573	chr12:123185601-123185602	Weak transcription Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs575994389	chr12:123185671-123185672	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs200799314	chr12:123185726-123185727	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs543404227	chr12:123185747-123185748	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs138619868	chr12:123185759-123185760	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs573958213	chr12:123185778-123185779	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs374385013	chr12:123185850-123185851	Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
31	rs199983835	chr12:123185864-123185865	Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
32	rs541259775	chr12:123185871-123185872	Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
33	rs559576902	chr12:123185878-123185879	Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
34	rs533310189	chr12:123185879-123185880	Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
35	rs545485411	chr12:123185882-123185883	Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
36	rs151219789	chr12:123185891-123185892	Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
37	rs370838546	chr12:123185896-123185897	Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
38	rs531221100	chr12:123185921-123185922	Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
39	rs549293990	chr12:123185926-123185927	Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
40	rs2936739	chr12:123185929-123185930	Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
41	rs1064104	chr12:123185947-123185948	Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
42	rs373564293	chr12:123185962-123185963	Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
43	rs369886325	chr12:123185974-123185975	Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
44	rs561592066	chr12:123185979-123185980	Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
45	rs575195499	chr12:123186004-123186005	Enhancers Bivalent Enhancer Active TSS Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
46	rs567293847	chr12:123186005-123186006	Enhancers Bivalent Enhancer Active TSS Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
47	rs140418074	chr12:123186006-123186007	Enhancers Bivalent Enhancer Active TSS Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
48	rs1055884	chr12:123186017-123186018	Enhancers Bivalent Enhancer Active TSS Weak transcription Flanking Active TSS	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs183998358	chr12:123186022-123186023	Enhancers Bivalent Enhancer Active TSS Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
50	rs147030932	chr12:123186064-123186065	Enhancers Bivalent Enhancer Active TSS Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a

Variant related diseases (count:68)

Disease	PMID	Source
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Ewing''s sarcoma	21437220	CNVD
Testicular germ cell tumor	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Basal cell lymphoma	17053054	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	21949216	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21637783	CNVD
Glioblastoma multiforme	21080181	CNVD
Renal cell carcinoma	19461508	CNVD
Burkitt''s lymphoma	18698080	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Lung cancer	18438408	CNVD
small cell lung cancer	20016488	CNVD
Glioblastoma multiforme	21390271	CNVD
Cancer	20164919	CNVD
Cancer	16751803	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Wilms tumour	21544195	CNVD
Ovarian cancer	21720365	CNVD
Colorectal cancer	16272173	CNVD
lymphocytic leukemia	21291569	CNVD
Breast cancer	16397240	CNVD
Breast cancer	17133270	CNVD
Breast cancer	17603634	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Schizophrenia	18923514	CNVD
Schizophrenia	22241247	CNVD
Cryptorchidism	21048976	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Neuroblastoma	18923191	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21806811	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Prostate cancer	18632612	CNVD
Myelofibrosis	22110671	CNVD
Beckwith-Wiedemann syndrome	20648245	CNVD
Developmental delay	21457577	CNVD
dysmorphic	21457577	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
Olfactory neuroblastoma	18408657	CNVD
Chordoma	18071362	CNVD

Chromatin state (count:91 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:123166600-123187800	Weak transcription	A549	lung
2	chr12:123174000-123199800	Weak transcription	Breast Myoepithelial Primary Cells	Breast
3	chr12:123181800-123185400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
4	chr12:123182600-123185200	Weak transcription	Adipose Nuclei	Adipose
5	chr12:123182600-123185200	Weak transcription	HMEC	breast
6	chr12:123182600-123185400	Weak transcription	NHEK	skin
7	chr12:123182800-123185200	Weak transcription	Primary neutrophils fromperipheralblood	blood
8	chr12:123183000-123185000	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
9	chr12:123183000-123185200	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
10	chr12:123183000-123185400	Weak transcription	Placenta	Placenta
11	chr12:123184000-123188800	Enhancers	Primary monocytes fromperipheralblood	blood
12	chr12:123184200-123185800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
13	chr12:123184800-123185200	Weak transcription	Monocytes-CD14+_RO01746	blood
14	chr12:123185000-123185400	Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
15	chr12:123185200-123185400	Active TSS	Adipose Nuclei	Adipose
16	chr12:123185200-123185800	Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
17	chr12:123185200-123186000	Active TSS	Primary neutrophils fromperipheralblood	blood
18	chr12:123185200-123186000	Enhancers	HMEC	breast
19	chr12:123185200-123186000	Enhancers	Monocytes-CD14+_RO01746	blood
20	chr12:123185200-123187200	Active TSS	Esophagus	oesophagus
21	chr12:123185400-123185600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
22	chr12:123185400-123185600	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
23	chr12:123185400-123185600	Flanking Active TSS	Adipose Nuclei	Adipose
24	chr12:123185400-123185600	Enhancers	Placenta	Placenta
25	chr12:123185400-123185600	Flanking Active TSS	NHEK	skin
26	chr12:123185400-123186200	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
27	chr12:123185400-123186800	Active TSS	Primary hematopoietic stem cells	blood
28	chr12:123185400-123188200	Active TSS	Primary B cells from cord blood	blood
29	chr12:123185600-123185800	Active TSS	Adipose Nuclei	Adipose
30	chr12:123185600-123185800	Enhancers	NHEK	skin
31	chr12:123185600-123186000	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
32	chr12:123185600-123186000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
33	chr12:123185600-123186000	Weak transcription	Placenta	Placenta
34	chr12:123185800-123186000	Enhancers	ES-I3 Cell Line	embryonic stem cell
35	chr12:123185800-123186000	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
36	chr12:123185800-123186000	Flanking Active TSS	NHEK	skin
37	chr12:123185800-123186200	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
38	chr12:123185800-123186200	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
39	chr12:123185800-123186400	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
40	chr12:123185800-123186400	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
41	chr12:123185800-123187000	Flanking Active TSS	Adipose Nuclei	Adipose
42	chr12:123186000-123186200	Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
43	chr12:123186000-123186200	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
44	chr12:123186000-123186400	Enhancers	NHLF	lung
45	chr12:123186000-123187400	Weak transcription	HMEC	breast
46	chr12:123186000-123188000	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
47	chr12:123186000-123188000	Enhancers	Placenta	Placenta
48	chr12:123186000-123188200	Enhancers	NHEK	skin
49	chr12:123186000-123188600	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
50	chr12:123186000-123188600	Flanking Active TSS	Monocytes-CD14+_RO01746	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links